Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,418 public trials 1,316 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Lamivudine(LAM) Good Responder Study

NCT01128686

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Kangwon-do, South Korea

View Trial Details

Completed

Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis

NCT01245257

Conditions: Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Hepatitis, +10 more
Locations: Department of Medicine V, Aarhus University Hospital Aarhus, Denmark

View Trial Details

Completed

THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.

NCT02381769

Conditions: Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Liver Disease, +5 more
Locations: Institute of Liver & Biliary Sciences New Delhi, National Capital Territory of Delhi, India

View Trial Details

Completed

Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™

NCT01061541

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity

NCT00197249

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age

NCT00697554

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Not specified

View Trial Details

Completed

Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters

NCT01962155

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +13 more
Locations: The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

302 Military Hospital of China Beijing, Beijing Municipality, China

Beijing Ditan Hospital Beijing, Beijing Municipality, China

Peking University First Hospital Beijing, Beijing Municipality, China

View all 30 locations

View Trial Details

Completed

A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

NCT00317174

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine

NCT00880477

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Not specified

View Trial Details

Completed

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

NCT00197171

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site Parramatta, New South Wales, Australia

GSK Investigational Site Melbourne, Victoria, Australia

View Trial Details

Liver Diseases

Liver Diseases trial results

Related conditions